Mustang Bio Statistics
NASDAQ: MBIOHealthcareBiotechnologyUSD
0.417-0.0332 (-7.37%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Mustang Bio by the numbers
Mustang Bio has a market capitalization of $3.2 million based on 6.73M shares outstanding. With trailing EPS of $-0.40, Mustang Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.6% below its 50-day average and 43.8% below its 200-day average.
Average daily trading volume is 29.38K shares, or about $12,252 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MBIO valuation vs. peer median
| Metric | MBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.16M | $3.25M | -3% |
| Avg. volume | 29.38K | 102.97K | -71% |
Peer median across 8 companies: REVB, KAPA, APVO, MLEC, CVKD, SILO, CMND, XRTX.
Valuation
- Market cap
- $3.16M
- EPS (TTM)
- $-0.40
- Shares outstanding
- 6.73M
Price and trading
- Previous close
- 0.4502
- Open
- 0.448
- Day range
- 0.4101 – 0.449
- 52-week range
- 0.41 – 1.81
- 50-day moving average
- 0.5385
- 200-day moving average
- 0.7422
- Beta
- —
- Volume
- 100.97K
- Average volume
- 29.38K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 3.16M
- Forward Pe
- -1.19
- Eps
- -0.40
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.81
- Week52 Low
- 0.41
- Avg Volume
- 29,381.00
- Shares Outstanding
- 6.73M
- Ma50
- 0.54
- Ma200
- 0.74
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -76.96%
- Pct From52w Low
- 1.71%